THE MODERATING EFFECTS OF DEPRESSION ON BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS

被引:0
|
作者
Rathbun, A. M. [1 ]
Harrold, L. R. [2 ]
Reed, G. W. [1 ]
机构
[1] Univ Massachusetts, Sch Med, Med, Worcester, MA 01605 USA
[2] Univ Massachusetts, Sch Med, Orthoped, Worcester, MA 01605 USA
关键词
D O I
10.1136/annrheumdis-2014-eular.3422
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
SAT0112
引用
收藏
页码:631 / 631
页数:1
相关论文
共 50 条
  • [41] USE OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS AND RISK OF MULTIPLE MYELOMA IN RHEUMATOID ARTHRITIS
    Tokareva, Y.
    Peterson, A.
    Baraff, A.
    Smith, N.
    Coffey, D.
    Weiss, N.
    Singh, N.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (01) : NP642 - NP643
  • [42] ABATACEPT IS A SUITABLE BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN PATIENTS WITH ANTI-SS-A ANTIBODIES-POSITIVE RHEUMATOID ARTHRITIS
    Horai, Y.
    Takatani, A.
    Nishino, A.
    Nakashima, Y.
    Suzuki, T.
    Fujikawa, K.
    Tsukada, T.
    Tsuboi, M.
    Matsuoka, N.
    Migita, K.
    Aramaki, T.
    Ueki, Y.
    Kawashiri, S. -Y.
    Iwamoto, N.
    Ichinose, K.
    Tamai, M.
    Nakamura, H.
    Origuchi, T.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 687 - 688
  • [43] DISEASE MODIFYING ANTI-RHEUMATIC DRUGS
    STECHER, VJ
    CARLSON, JA
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, 1983, 18 : 171 - 179
  • [44] Recurrent infections in a rheumatoid arthritis patient with a primary immunodeficiency, treated with conventional and biologic disease-modifying anti-rheumatic drugs
    Diamantopoulos, Andreas P.
    Haugeberg, Glenn
    MODERN RHEUMATOLOGY, 2012, 22 (02) : 295 - 297
  • [45] Two Cases of High Tibial Osteotomy in Patients with Rheumatoid Arthritis Treated with Biologic Disease-modifying Anti-rheumatic Drugs
    Takahara, Yasuhiro
    Nishida, Keiichiro
    Nakashima, Hirotaka
    Ochi, Nobuaki
    Uchida, Yoichiro
    Kato, Hisayoshi
    Itani, Satoru
    Nakamura, Makoto
    Iwasaki, Yuichi
    Tsujimura, Yoshitaka
    ACTA MEDICA OKAYAMA, 2019, 73 (06) : 537 - 542
  • [46] Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients
    Convertino, Irma
    Cazzato, Massimiliano
    Tillati, Silvia
    Giometto, Sabrina
    Gini, Rosa
    Valdiserra, Giulia
    Cappello, Emiliano
    Ferraro, Sara
    Bonaso, Marco
    Bartolini, Claudia C.
    Paoletti, Olga
    Lorenzoni, Valentina
    Filippi, Matteo
    Turchetti, Giuseppe
    Cristofano, Michele
    Blandizzi, Corrado
    Mosca, Marta
    Lucenteforte, Ersilia
    Tuccori, Marco
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 488 - 489
  • [47] USE OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS IN RELATION TO THE RISK OF LYMPHOMA: A COHORT STUDY OF US VETERANS WITH RHEUMATOID ARTHRITIS
    Singh, N.
    Peterson, A.
    Baraff, A.
    Korpak, A.
    Vaughan-Sarrazin, M.
    Smith, N.
    Curtis, J.
    Weiss, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 369 - 369
  • [48] A mixed treatment comparison of the short-term efficacy of biologic disease modifying anti-rheumatic drugs in established rheumatoid arthritis
    Turkstra, E.
    Ng, S. -K.
    Scuffham, P. A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (10) : 1885 - 1897
  • [49] Estimation of Cost per Effectively Treated Patients with Biologic Disease Modifying Anti-Rheumatic Drugs in US Veterans with Rheumatoid Arthritis
    Cannon, Grant W.
    Teng, Chia-Chen
    He, Tao
    Leng, Jianwei
    Lu, Chao-Chin
    Tang, Derek
    Shah, Neel
    Harrison, David J.
    Sauer, Brian
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S213 - S213
  • [50] FACTORS PREDICTING THE INITIATION OF BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUGS FOR RHEUMATOID ARTHRITIS WITHIN THE FIRST THREE YEARS OF DIAGNOSIS
    Hameed, M.
    Exarchou, S.
    Eberhard, A.
    Sharma, A.
    Bergstrom, U.
    Cagnotto, G.
    Einarsson, J. T.
    Turesson, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1393 - 1394